Executives from 15 rare disease-focused nonprofits met on Wednesday with acting FDA Commissioner Kyle Diamantas. In the meeting, Diamantas made it clear he's headed in a different direction from Marty Makary, particularly when it comes to listening to career staff on new drug approvals.
Executives from 15 rare disease-focused nonprofits met on Wednesday with acting FDA Commissioner Kyle Diamantas and senior staff.
In the meeting, Diamantas made it clear …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Acting FDA commissioner Kyle Diamantas doesn't want the permanent job, and the search for a replacement is progressing, a source…
Kyle Diamantas, who was elevated to FDA acting commissioner earlier this week, is telling anti-abortion groups he asked to be…
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida…
Kyle Diamantas doesn't have the typical CV for an FDA commissioner, but he's earning early praise.
With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across…
With the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can…
